Be vigilant about falsified weight-loss drugs, WHO warns [FOX Business Network]
![FOX Business Network](../../../Content/images/providers/FOX Business Network.png)
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: FOX Business Network
The general public and professionals should be vigilant about falsified weight-loss medications, the World Health Organization (WHO) said Thursday. The international public health agency specifically raised the alarm about counterfeits of semaglutide drugs that people frequently use to facilitate weight loss. Its warning focused on three batches of fake Ozempic that appeared in Brazil, the U.K. and the U.S. late last year. They were not made by Novo Nordisk, the producer of real Ozempic Ticker Security Last Change Change % NVO NOVO NORDISK A/S Powered By "These falsified products could have harmful effects to people's health," the WHO said . "If the products don't have the necessary raw components, falsified medicines can lead to health complications resulting from unmanaged blood glucose levels or weight. In other cases, another undeclared active ingredient may be contained in the injection device, e.g. insulin, leading to an unpredictable range of health risks
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- 6 Top Weight Loss Stocks To Buy Now [Forbes]Forbes
- Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma [Yahoo! Finance]Yahoo! Finance
- 2seventy bio completes $40m haemophilia A program deal with Novo Nordisk [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk To Restrict Initial Wegovy Sales In China Amid High Demand [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk's (NVO) Hypertension Drug Study Fails to Meet Goal [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 5/3/24 - Beat
NVO
Sec Filings
- 6/26/24 - Form 6-K
- 6/24/24 - Form 6-K
- 6/21/24 - Form 11-K
- NVO's page on the SEC website